SCHEMBL8202703

SCHEMBL8202703

CC[C@@H](C)[C@@H](NC(=O)N1CCC2(CC1)C(=O)N(c1cccc(F)c1)C2c1ccc(Cl)cc1)C(N)=O

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8202215 1.00 CACNA1H (0.84) CACNA1H
SCHEMBL8210031 0.93 CACNA1H (0.86) CACNA1H
SCHEMBL8210567 0.93 CACNA1H (0.86) CACNA1H
SCHEMBL12876764 0.92 CACNA1H (1.00) CACNA1H
SCHEMBL8212811 0.92 CACNA1H (1.00) CACNA1H
SCHEMBL8209964 0.92 CACNA1H (1.00) CACNA1H
SCHEMBL8201891 0.91 CACNA1H (0.69) CACNA1H
SCHEMBL8212697 0.90 CACNA1H (1.00) CACNA1H
SCHEMBL8209528 0.90 CACNA1H (1.00) CACNA1H
SCHEMBL8201886 0.89 CACNA1H (1.00) CACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008033464-A2 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF DISORDERS OF THE LIPID METABOLISM SCHERING CORPORATION (US) 2008-03-20 WO disclosed